The Latest Breaking News from Centene

Benzinga's Top Ratings Upgrades, Downgrades For September 30, 2022

Upgrades

Benzinga · Sep 30, 2022

Health plan shake-up could disrupt coverage for low-income Californians

Almost 2 million of California’s poorest and most medically fragile residents may have to switch health insurers as a result of a new strategy by the state to improve care in its Medicaid program.

Tribune News Service · Sep 30, 2022

Centene to pay $166 million to Texas in Medicaid drug pricing settlement

Health insurance giant Centene Corp. has agreed to pay $165.6 million to Texas to resolve claims that it overcharged the state’s Medicaid program for pharmacy services.

Tribune News Service · Sep 19, 2022

Analyzing Centene's Short Interest

Centene's (NYSE:CNC) short percent of float has risen 55.64% since its last report. The company recently reported that it has 8.31 million shares sold short, which is 2.07% of all regular shares that are available for trading.

Benzinga · Jun 29, 2022

If You Invested $100 In This Stock 5 Years Ago, You Would Have $200 Today

Centene (NYSE:CNC) has outperformed the market over the past 5 years by 6.23% on an annualized basis producing an average annual return of 16.19%. Currently, Centene has a market capitalization of $49.46 billion.

Benzinga · Jun 27, 2022

Executives Sell More Than $67M Of 5 Stocks: NetApp, Eli Lilly And More

US gold futures traded lower on Friday. Investors, meanwhile, focused on some notable insider trades.

Benzinga · Jun 24, 2022

Benzinga's Top Ratings Upgrades, Downgrades For June 21, 2022

Upgrades

Benzinga · Jun 21, 2022

Centene Lifts FY22 Guidance On Higher Medicaid Premiums; Increases Share Buyback

Ahead of its investor day, Centene Corp (NYSE:CNC) increased its Premium and Service Revenues FY22 guidance range by $2.0 billion to $134.3 billion - $136.3 billion. The company also increased adjusted EPS guidance by $0.15 to $5.55 - $5.70 vs. the consensus of $5.49. The company's 2022 financial guidance has been updated to…

Benzinga · Jun 17, 2022

Where Centene Stands With Analysts

Over the past 3 months, 5 analysts have published their opinion on Centene (NYSE:CNC) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga · Jun 17, 2022

Britain’s biggest chain of GP surgeries accused of ‘profiteering’

BBC Panorama claims Operose Health uses physician associates, who are cheaper to employ than doctors, to assess patients

The Guardian - UK · Jun 13, 2022